Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

64.47
Delayed Data
As of Mar 28
 +0.08 / +0.12%
Today’s Change
32.40
Today|||52-Week Range
75.36
+22.17%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close64.39
Today’s open64.54
Day’s range64.05 - 65.44
Volume448,053
Average volume (3 months)1,093,105
Market cap$9.2B
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-72.87%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book14.46

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.03+0.05%
JAZZJazz Pharmaceuticals...-1.07-0.73%
PRGOPerrigo Company PLC-0.27-0.39%
TSROTESARO Inc-1.83-1.17%
Data as of 03/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts


Search for Jobs